Chemoinformaics analysis of ajmalan-17-ol, 19,20-didehydro-, (17r,19e)-(9ci)
| Molecular Weight | 308.425 | nRot | 0 |
| Heavy Atom Molecular Weight | 284.233 | nRig | 25 |
| Exact Molecular Weight | 308.189 | nRing | 7 |
| Solubility: LogS | -3.87 | nHRing | 5 |
| Solubility: LogP | 2.191 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 5 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 52.405 |
| nHD | 1 | BPOL | 27.497 |
| QED | 0.744 |
| Synth | 6.421 |
| Natural Product Likeliness | 2.411 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.383 |
| Pgp-sub | 0.858 |
| HIA | 0.977 |
| CACO-2 | -4.798 |
| MDCK | 0.0000214 |
| BBB | 0.981 |
| PPB | 0.75733 |
| VDSS | 3.148 |
| FU | 0.239505 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.11 |
| CYP2c19-inh | 0.065 |
| CYP2c19-sub | 0.909 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.269 |
| CYP2d6-inh | 0.36 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.625 |
| CYP3a4-sub | 0.791 |
| CL | 11.7 |
| T12 | 0.124 |
| hERG | 0.022 |
| Ames | 0.084 |
| ROA | 0.754 |
| SkinSen | 0.126 |
| Carcinogencity | 0.825 |
| EI | 0.011 |
| Respiratory | 0.936 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.664561 |